CDC: Average U.S. life expectancy hit record high in 2024

U.S. life expectancy reached a record 79.0 years in 2024, up more than half a year from 2023, as the CDC's National Center for Health Statistics reports a roughly 3.8% decline in the age-adjusted death rate and 18,298 fewer deaths (just over 3 million total) than in 2023. Gains were larger for males (+0.2 years) than females (+0.1 years) — female life expectancy 81.4 vs. male 76.5 — and increased across all recorded races and ethnicities; COVID-19 fell out of the top 10 causes of death (replaced by suicide), while heart disease, cancer and unintentional injuries remained the top three and all saw lower age-adjusted death rates. Deaths from drug overdoses declined and age-specific death rates fell for all groups aged 1 and older except ages 5–14, though U.S. life expectancy still trails several developed peers such as Australia, Spain and Japan.

Analysis

Market structure: A durable uptick in U.S. life expectancy (up ~0.5 year to 79 in 2024) shifts demand by modest amounts toward chronic-care services, Medicare Advantage and senior housing over 1–10+ years, benefiting hospital systems, MA players and healthcare REITs (WELL, VTR, UNH, HUM). Insurers with large annuity books (PRU, LNC) face higher long-term liabilities, while term life writers may see fewer near-term payouts; net impact depends on hedging/reainsurance positions and reserve assumptions adjusted over the next 1–4 quarters.

Risk assessment: Tail risks include a new pandemic or rapid drug-resistant disease (weeks–months) that could reverse mortality gains, and adverse regulatory changes (drug pricing/Medicare reimbursement) over 6–24 months that compress provider margins. Hidden dependency: actuaries update mortality tables annually—if firms accelerate reserve increases in upcoming quarterly filings (next 1–2 quarters), equity re-rating could be sharp (-10–25% for under-hedged insurers). Catalysts: insurer reserve disclosures, SSA/CDC follow-ups, and OMB/policy moves on Medicare Advantage rates within 3–12 months.

Trade implications: Tactical: prefer 6–18 month longs in Medicare Advantage leaders (UNH, HUM) and senior-housing REITs (WELL, VTR) sized 1–3% each, and pair short exposure to annuity-heavy life insurers (PRU, LNC) sized 1–3% or buy protective puts (3–9 month). Options: buy 3–6 month puts 8–12% OTM on PRU/LNC (cost <2–3% premium) and sell 6–9 month covered calls on UNH/HUM to fund positions. Cross-asset: municipal healthcare credits and long-duration munis may attract demand from pension de-risking over 1–5 years.

Contrarian angles: Consensus underestimates reserve shock risk at annuity writers—if mortality improvements persist 0.2–0.5% annually, PV of liabilities rises materially (single-digit % to low-double-digit % for older cohorts), creating mispricing in PRU/LNC; conversely senior-housing REIT valuations may already price in demand and rising operating costs (labor/regulation) so target selective names (WELL over VTR). Historical parallel: post-pandemic mortality rebounds can plateau; avoid levering duration risk until two consecutive years of trend confirmed by CDC/SSA (12–24 months).

Key Decisions for Investors

• Establish a 2–3% long position in UNH and a 1–2% long in HUM within 30 days, targeting 6–18 month horizon to capture Medicare Advantage tailwinds; trim if shares rise >15% or if CMS MA rate guidance weakens.
• Initiate a 2% short position in PRU or LNC (or equivalent via 3–6 month 8–12% OTM puts if selling stock not possible); size to limit portfolio delta and reduce if insurer reserve increases are smaller than +5% of book value on quarterly filings.
• Buy 3–6 month puts on PRU and LNC (cost budget ~1.5–3% premium) to hedge annuity longevity risk ahead of quarterly actuarial updates; take profits if implied vol rises >30% or CDC issues contrary mortality data.
• Allocate 1–2% to senior-housing REITs (WELL > VTR) with 12–36 month hold; prefer REITs with >50% exposure to triple-net/medical office and tenants tied to Medicare reimbursements, exit on occupancy decline >200 bps y/y or NOI contraction >5%.
• Shift 3–5% of fixed-income sleeve toward high-quality long-duration municipal healthcare bonds over 6–24 months as pension/insurer demand for duration likely increases; sell if 10y muni-Treasury spread tightens >50 bps from current levels.